Advertisement

Cardiac Cachexia Revisited

The Role of Wasting in Heart Failure
  • Miroslava Valentova
    Affiliations
    Department of Cardiology and Pneumology, University Medical Center Göttingen, Robert-Koch-Street 40, 37075 Göttingen, Germany

    DZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, Robert-Koch-Street 40, 37075 Göttingen, Germany
    Search for articles by this author
  • Stefan D. Anker
    Affiliations
    Division of Cardiology and Metabolism, Department of Cardiology (CVK), Berlin-Brandenburg Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
    Search for articles by this author
  • Stephan von Haehling
    Correspondence
    Corresponding author. Department of Cardiology and Pneumology, University Medical Center Göttingen, Robert-Koch-Street 40, 37075 Göttingen, Germany.
    Affiliations
    Department of Cardiology and Pneumology, University Medical Center Göttingen, Robert-Koch-Street 40, 37075 Göttingen, Germany

    DZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, Robert-Koch-Street 40, 37075 Göttingen, Germany
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kenchaiah S.
        • Evans J.C.
        • Levy D.
        • et al.
        Obesity and the risk of heart failure.
        N Engl J Med. 2002; 347: 305-313
        • Voulgari C.
        • Tentolouris N.
        • Dilaveris P.
        • et al.
        Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.
        J Am Coll Cardiol. 2011; 58: 1343-1350
        • Horwich T.B.
        • Fonarow G.C.
        • Hamilton M.A.
        • et al.
        The relationship between obesity and mortality in patients with heart failure.
        J Am Coll Cardiol. 2001; 38: 789-795
        • Khalid U.
        • Ather S.
        • Bavishi C.
        • et al.
        Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.
        J Am Coll Cardiol. 2014; 64: 2743-2749
        • Oreopoulos A.
        • Padwal R.
        • Kalantar-Zadeh K.
        • et al.
        Body mass index and mortality in heart failure: a meta-analysis.
        Am Heart J. 2008; 156: 13-22
        • Zhang J.
        • Begley A.
        • Jackson R.
        • et al.
        Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis.
        Clin Res Cardiol. 2019; 108: 119-132
        • Doehner W.
        • von Haehling S.
        • Anker S.D.
        Protective overweight in cardiovascular disease: moving from “paradox” to “paradigm.
        Eur Heart J. 2015; 36: 2729-2732
        • Anker S.D.
        • Ponikowski P.
        • Varney S.
        • et al.
        Wasting as independent risk factor for mortality in chronic heart failure.
        Lancet. 1997; 349: 1050-1053
        • Remme W.J.
        • Swedberg K.
        Guidelines for the diagnosis and treatment of chronic heart failure.
        Eur Heart J. 2001; 22: 1527-1560
        • McMurray J.J.V.
        • Adamopoulos S.
        • Anker S.D.
        • et al.
        ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012.
        Eur Heart J. 2012; 33: 1787-1847
        • Ponikowski P.
        • Voors A.A.
        • Anker S.D.
        • et al.
        2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
        Eur J Heart Fail. 2016; 18: 891-975
        • Tromp J.
        • Westenbrink B.D.
        • Ouwerkerk W.
        • et al.
        Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction.
        J Am Coll Cardiol. 2018; 72: 1081-1090
        • Buckinx F.
        • Landi F.
        • Cesari M.
        • et al.
        Pitfalls in the measurement of muscle mass: a need for a reference standard.
        J Cachexia Sarcopenia Muscle. 2018; 9: 269-278
        • Forman D.E.
        • Santanasto A.J.
        • Boudreau R.
        • et al.
        Impact of incident heart failure on body composition over time in the health ABC study population.
        Circ Heart Fail. 2017; 10 ([pii:e003915])
        • von Haehling S.
        The wasting continuum in heart failure: from sarcopenia to cachexia.
        Proc Nutr Soc. 2015; 74: 367-377
        • Valentova M.
        • von Haehling S.
        • Bauditz J.
        • et al.
        Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure.
        Eur Heart J. 2016; 37: 1684-1691
        • Melenovsky V.
        • Kotrc M.
        • Borlaug B.A.
        • et al.
        Relationships between right ventricular function, body composition, and prognosis in advanced heart failure.
        J Am Coll Cardiol. 2013; 62: 1660-1670
        • Anker S.D.
        • Ponikowski P.P.
        • Clark A.L.
        • et al.
        Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.
        Eur Heart J. 1999; 20: 683-693
        • Emami A.
        • Saitoh M.
        • Valentova M.
        • et al.
        Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
        Eur J Heart Fail. 2018; 20: 1580-1587
        • Florea V.G.
        • Moon J.
        • Pennell D.J.
        • et al.
        Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study.
        Int J Cardiol. 2004; 97: 15-20
        • Anker S.D.
        • Clark A.L.
        • Teixeira M.M.
        • et al.
        Loss of bone mineral in patients with cachexia due to chronic heart failure.
        Am J Cardiol. 1999; 83: 612-615
        • von Haehling S.
        • Anker M.S.
        • Anker S.D.
        Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016.
        J Cachexia Sarcopenia Muscle. 2016; 7: 507-509
        • Anker S.D.
        • Negassa A.
        • Coats A.J.
        • et al.
        Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
        Lancet. 2003; 361: 1077-1083
        • Evans W.J.
        • Morley J.E.
        • Argilés J.
        • et al.
        Cachexia: a new definition.
        Clin Nutr. 2008; 27: 793-799
        • Sullivan D.H.
        • Johnson L.E.
        • Bopp M.M.
        • et al.
        Prognostic significance of monthly weight fluctuations among older nursing home residents.
        J Gerontol A Biol Sci Med Sci. 2004; 59: M633-M639
        • Anker S.D.
        • Morley J.E.
        Cachexia: a nutritional syndrome?.
        J Cachexia Sarcopenia Muscle. 2015; 6: 269-271
        • von Haehling S.
        Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature.
        ESC Heart Fail. 2018; 5: 1074-1082
        • Fülster S.
        • Tacke M.
        • Sandek A.
        • et al.
        Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).
        Eur Heart J. 2013; 34: 512-519
        • Bekfani T.
        • Pellicori P.
        • Morris D.A.
        • et al.
        Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life.
        Int J Cardiol. 2016; 222: 41-46
        • Hajahmadi M.
        • Shemshadi S.
        • Khalilipur E.
        • et al.
        Muscle wasting in young patients with dilated cardiomyopathy.
        J Cachexia Sarcopenia Muscle. 2017; 8: 542-548
        • Florea V.G.
        • Henein M.Y.
        • Rauchhaus M.
        • et al.
        The cardiac component of cardiac cachexia.
        Am Heart J. 2002; 144: 45-50
        • Giannakopoulos G.
        • Roffi M.
        • Frangos C.
        • et al.
        Symptom improvement and cachexia reversal in an 84-year-old woman after percutaneous closure of atrial septal defect.
        J Am Geriatr Soc. 2015; 63: 416-418
        • le Roux C.W.
        • Ghatei M.A.
        • Gibbs J.S.R.
        • et al.
        The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension.
        Heart. 2005; 91: 241-242
        • Christensen H.M.
        • Kistorp C.
        • Schou M.
        • et al.
        Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.
        Endocrine. 2013; 43: 626-634
        • Gaggin H.K.
        • Belcher A.M.
        • Gandhi P.U.
        • et al.
        Serial echocardiographic characteristics, novel biomarkers and cachexia development in patients with stable chronic heart failure.
        J Cardiovasc Transl Res. 2016; 9: 429-431
        • Ishida J.
        • Saitoh M.
        • Doehner W.
        • et al.
        Animal models of cachexia and sarcopenia in chronic illness: cardiac function, body composition changes and therapeutic results.
        Int J Cardiol. 2017; 238: 12-18
        • Argilés J.M.
        • Busquets S.
        • Stemmler B.
        • et al.
        Cancer cachexia: understanding the molecular basis.
        Nat Rev Cancer. 2014; 14: 754-762
        • Bei Y.
        • Xiao J.
        MicroRNAs in muscle wasting and cachexia induced by heart failure.
        Nat Rev Cardiol. 2017; 14: 566
        • Thompson M.P.
        • Cooper S.T.
        • Parry B.R.
        • et al.
        Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients.
        Biochim Biophys Acta. 1993; 1180: 236-242
        • Moro C.
        • Galitzky J.
        • Sengenes C.
        • et al.
        Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
        J Pharmacol Exp Ther. 2004; 308: 984-992
        • Anker S.D.
        • Sharma R.
        The syndrome of cardiac cachexia.
        Int J Cardiol. 2002; 85: 51-66
        • Ferrara R.
        • Mastrorilli F.
        • Pasanisi G.
        • et al.
        Neurohormonal modulation in chronic heart failure.
        Eur Heart J Suppl. 2002; 4: D3-D11
        • Yoshida T.
        • Delafontaine P.
        Mechanisms of cachexia in chronic disease states.
        Am J Med Sci. 2015; 350: 250-256
        • Jackman R.W.
        • Kandarian S.C.
        The molecular basis of skeletal muscle atrophy.
        Am J Physiol Cell Physiol. 2004; 287: C834-C843
        • Braun T.P.
        • Marks D.L.
        Pathophysiology and treatment of inflammatory anorexia in chronic disease.
        J Cachexia Sarcopenia Muscle. 2010; 1: 135-145
        • Castillo-Martínez L.
        • Orea-Tejeda A.
        • Rosales M.T.
        • et al.
        Anthropometric variables and physical activity as predictors of cardiac cachexia.
        Int J Cardiol. 2005; 99: 239-245
        • Suzuki H.
        • Asakawa A.
        • Amitani H.
        • et al.
        Cancer cachexia—pathophysiology and management.
        J Gastroenterol. 2013; 48: 574-594
        • Barazzoni R.
        • Gortan Cappellari G.
        • Palus S.
        • et al.
        Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure.
        J Cachexia Sarcopenia Muscle. 2017; 8: 991-998
        • King D.
        • Smith M.L.
        • Chapman T.J.
        • et al.
        Fat malabsorption in elderly patients with cardiac cachexia.
        Age Ageing. 1996; 25: 144-149
        • Arutyunov G.P.
        • Kostyukevich O.I.
        • Serov R.A.
        • et al.
        Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure.
        Int J Cardiol. 2008; 125: 240-245
        • Sandek A.
        • Bjarnason I.
        • Volk H.-D.
        • et al.
        Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure.
        Int J Cardiol. 2012; 157: 80-85
        • King D.
        • Smith M.L.
        • Lye M.
        Gastro-intestinal protein loss in elderly patients with cardiac cachexia.
        Age Ageing. 1996; 25: 221-223
        • Sandek A.
        • Swidsinski A.
        • Schroedl W.
        • et al.
        Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia.
        J Am Coll Cardiol. 2014; 64: 1092-1102
        • Turnbaugh P.J.
        • Ley R.E.
        • Mahowald M.A.
        • et al.
        An obesity-associated gut microbiome with increased capacity for energy harvest.
        Nature. 2006; 444: 1027-1031
        • Luedde M.
        • Winkler T.
        • Heinsen F.-A.
        • et al.
        Heart failure is associated with depletion of core intestinal microbiota.
        ESC Heart Fail. 2017; 4: 282-290
        • Clark A.L.
        • Coats A.J.S.
        • Krum H.
        • et al.
        Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial.
        J Cachexia Sarcopenia Muscle. 2017; 8: 549-556
        • Cohen-Solal A.
        • Jacobson A.F.
        • Piña I.L.
        Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance.
        ESC Heart Fail. 2017; 4: 499-506
        • Stephan G.
        • Marcus S.
        • Irina K.
        • et al.
        Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age.
        Circulation. 2012; 125: 2716-2727
        • Rozentryt P.
        • von Haehling S.
        • Lainscak M.
        • et al.
        The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study.
        J Cachexia Sarcopenia Muscle. 2010; 1: 35-42
        • Anker S.D.
        • Comin Colet J.
        • Filippatos G.
        • et al.
        Ferric carboxymaltose in patients with heart failure and iron deficiency.
        N Engl J Med. 2009; 361: 2436-2448
        • Ponikowski P.
        • van Veldhuisen D.J.
        • Comin-Colet J.
        • et al.
        Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.
        Eur Heart J. 2015; 36: 657-668
        • Caminiti G.
        • Volterrani M.
        • Iellamo F.
        • et al.
        Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.
        J Am Coll Cardiol. 2009; 54: 919-927
        • Iellamo F.
        • Volterrani M.
        • Caminiti G.
        • et al.
        Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.
        J Am Coll Cardiol. 2010; 56: 1310-1316
        • Stout M.
        • Tew G.A.
        • Doll H.
        • et al.
        Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study.
        Am Heart J. 2012; 164: 893-901
        • Dziegala M.
        • Josiak K.
        • Kasztura M.
        • et al.
        Iron deficiency as energetic insult to skeletal muscle in chronic diseases.
        J Cachexia Sarcopenia Muscle. 2018; 9: 802-815
        • Tkaczyszyn M.
        • Drozd M.
        • Węgrzynowska-Teodorczyk K.
        • et al.
        Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure.
        J Cachexia Sarcopenia Muscle. 2018; 9: 547-556
        • Noritoshi N.
        • Masaaki U.
        • Masayasu K.
        • et al.
        Elevated circulating level of ghrelin in cachexia associated with chronic heart failure.
        Circulation. 2001; 104: 2034-2038
        • Davos C.H.
        • Doehner W.
        • Rauchhaus M.
        • et al.
        Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
        J Card Fail. 2003; 9: 29-35
        • Habedank D.
        • Meyer F.J.
        • Hetzer R.
        • et al.
        Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure.
        J Cachexia Sarcopenia Muscle. 2013; 4: 277-285
        • Szabó T.
        • Scherbakov N.
        • Sandek A.
        • et al.
        Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
        Nutr Metab Cardiovasc Dis. 2014; 24: 50-56
        • Santos N.F.D.
        • Pinho C.P.S.
        • Cardoso A.J.P.F.
        • et al.
        Cachexia in hospitalized patients with heart failure.
        Nutr Hosp. 2018; 35: 669-676
        • Beaudart C.
        • McCloskey E.
        • Bruyère O.
        • et al.
        Sarcopenia in daily practice: assessment and management.
        BMC Geriatr. 2016; 16: 170